comparemela.com

Page 2 - Shunqi Yan News Today : Breaking News, Live Updates & Top Stories | Vimarsana

ARTHROSI COMPLETES AR882 PHASE 2B STUDY ENROLLMENT

/PRNewswire/ Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company, today announced the completion of enrollment for its global Phase 2b.

ARTHROSI COMPLETES AR882 RENAL IMPAIRMENT STUDY

/PRNewswire/ Arthrosi Therapeutics, Inc., a clinical-stage biotechnology company focused on treatment for the management of gout, today announced the.

vimarsana © 2020. All Rights Reserved.